C. Schofield, J. Jannin, and R. Salvatella, The future of Chagas disease control, Trends in Parasitology, vol.22, issue.12, pp.583-588, 2006.
DOI : 10.1016/j.pt.2006.09.011

J. Coura, Chagas disease: what is known and what is needed?a background article, Mem Inst Oswaldo Cruz, vol.102, pp.113-122, 2007.

L. Kirchhoff, L. Weiss, M. Wittner, and H. Tanowitz, Parasitic diseases of the heart, Frontiers in Bioscience, vol.9, issue.1-3, pp.706-723, 2004.
DOI : 10.2741/1255

A. Barbosa, C. Neto, A. Otaviano, A. Rocha, B. Bestetti et al., Compara????o do desfecho entre a cardiopatia chag??sica e a miocardiopatia dilatada idiop??tica, Arquivos Brasileiros de Cardiologia, vol.97, issue.6, pp.517-525, 2011.
DOI : 10.1590/S0066-782X2011005000112

R. Bestetti and G. Muccillo, Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy, International Journal of Cardiology, vol.60, issue.2, pp.187-193, 1997.
DOI : 10.1016/S0167-5273(97)00083-1

A. Bafica, H. Santiago, R. Goldszmid, C. Ropert, R. Gazzinelli et al., Cutting Edge: TLR9 and TLR2 Signaling Together Account for MyD88-Dependent Control of Parasitemia in Trypanosoma cruzi Infection, The Journal of Immunology, vol.177, issue.6, pp.3515-3519, 2006.
DOI : 10.4049/jimmunol.177.6.3515

M. Reis, L. Higuchi-mde, L. Benvenuti, V. Aiello, P. Gutierrez et al., Anin SituQuantitative Immunohistochemical Study of Cytokines and IL-2R+in Chronic Human Chagasic Myocarditis: Correlation with the Presence of MyocardialTrypanosoma cruziAntigens, Clinical Immunology and Immunopathology, vol.83, issue.2, pp.165-172, 1997.
DOI : 10.1006/clin.1997.4335

A. Bilate and E. Cunha-neto, Chagas disease cardiomyopathy: current concepts of an old disease, Revista do Instituto de Medicina Tropical de S??o Paulo, vol.50, issue.2, pp.67-74, 2008.
DOI : 10.1590/S0036-46652008000200001

U. Muller, G. Kohler, H. Mossmann, G. Schaub, G. Alber et al., IL-12-Independent IFN-?? Production by T Cells in Experimental Chagas' Disease Is Mediated by IL-18, The Journal of Immunology, vol.167, issue.6, pp.3346-3353, 2001.
DOI : 10.4049/jimmunol.167.6.3346

R. Rodrigues, D. Dos-reis, M. Romano, A. Pereira, S. et al., In situ expression of regulatory cytokines by heart inflammatory cells in Chagas' disease patients with heart failure, Clin Dev Immunol, p.361730, 2012.

M. Ribeirao, V. Pereira-chioccola, L. Renia, A. F. Filho, A. Schenkman et al., Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase, Parasite Immunology, vol.22, issue.1, pp.49-53, 2000.
DOI : 10.1046/j.1365-3024.2000.00260.x

E. Cunha-neto, V. Dzau, P. Allen, D. Stamatiou, L. Benvenutti et al., Cardiac Gene Expression Profiling Provides Evidence for Cytokinopathy as a Molecular Mechanism in Chagas' Disease Cardiomyopathy, The American Journal of Pathology, vol.167, issue.2, pp.305-313, 2005.
DOI : 10.1016/S0002-9440(10)62976-8

E. Cunha-neto and K. J. , Heart-infiltrating and Peripheral T Cells in the Pathogenesis of Human Chagas' Disease Cardiomyopathy, Autoimmunity, vol.31, issue.3, pp.187-192, 2001.
DOI : 10.1590/S0100-879X1998000100018

A. Talvani, M. Rocha, L. Barcelos, Y. Gomes, A. Ribeiro et al., Elevated Concentrations of CCL2 and Tumor Necrosis Factor????? in Chagasic Cardiomyopathy, Clinical Infectious Diseases, vol.38, issue.7, pp.943-950, 2004.
DOI : 10.1086/381892

J. Gomes, L. Bahia-oliveira, M. Rocha, O. Martins-filho, G. Gazzinelli et al., Evidence that Development of Severe Cardiomyopathy in Human Chagas' Disease Is Due to a Th1-Specific Immune Response, Infection and Immunity, vol.71, issue.3, pp.711185-1193, 2003.
DOI : 10.1128/IAI.71.3.1185-1193.2003

A. Talvani, M. Rocha, A. Ribeiro, R. Correa-oliveira, and M. Teixeira, Chemokine Receptor Expression on the Surface of Peripheral Blood Mononuclear Cells in Chagas Disease, The Journal of Infectious Diseases, vol.189, issue.2, pp.214-220, 2004.
DOI : 10.1086/380803

F. Araujo, J. Gomes, M. Rocha, S. Williams-blangero, V. Pinheiro et al., Potential role of CD4+CD25HIGH regulatory T cells in morbidity in Chagas disease, Frontiers in Bioscience, vol.12, issue.1, pp.2797-2806, 2007.
DOI : 10.2741/2273

P. Guedes, F. Gutierrez, G. Silva, R. Dellalibera-joviliano, G. Rodrigues et al., Deficient Regulatory T Cell Activity and Low Frequency of IL-17-Producing T Cells Correlate with the Extent of Cardiomyopathy in Human Chagas' Disease, PLoS Neglected Tropical Diseases, vol.46, issue.4, p.1630
DOI : 10.1371/journal.pntd.0001630.t001

L. Magalhaes, F. Villani, N. Mdo, C. Gollob, K. Rocha et al., High Interleukin 17 Expression Is Correlated With Better Cardiac Function in Human Chagas Disease, Journal of Infectious Diseases, vol.207, issue.4, pp.661-665
DOI : 10.1093/infdis/jis724

L. Abel, L. Rizzo, B. Ianni, F. Albuquerque, F. Bacal et al., Chronic Chagas' Disease Cardiomyopathy Patients Display an Increased IFN-?? Response to Trypanosoma cruzi Infection, Journal of Autoimmunity, vol.17, issue.1, pp.99-107, 2001.
DOI : 10.1006/jaut.2001.0523

D. Reis, E. Jones, S. Tostes, E. Lopes, E. Chapadeiro et al., Expression of major histocompatibility complex antigens and adhesion molecules in hearts of patients with chronic Chagas' disease, Am J Trop Med Hyg, vol.49, issue.2, pp.192-200, 1993.

L. Nogueira, R. Santos, B. Ianni, A. Fiorelli, E. Mairena et al., Myocardial Chemokine Expression and Intensity of Myocarditis in Chagas Cardiomyopathy Are Controlled by Polymorphisms in CXCL9 and CXCL10, PLoS Neglected Tropical Diseases, vol.93, issue.1, p.1867
DOI : 10.1371/journal.pntd.0001867.s012

J. Gomes, L. Bahia-oliveira, M. Rocha, S. Busek, M. Teixeira et al., Type 1 Chemokine Receptor Expression in Chagas' Disease Correlates with Morbidity in Cardiac Patients, Infection and Immunity, vol.73, issue.12, pp.737960-7966, 2005.
DOI : 10.1128/IAI.73.12.7960-7966.2005

F. Zicker, P. Smith, J. Netto, R. Oliveira, and E. Zicker, Physical activity, opportunity for reinfection, and sibling history of heart disease as risk factors for Chagas' cardiopathy, Am J Trop Med Hyg, vol.43, issue.5, pp.498-505, 1990.

E. Llop, F. Rothhammer, M. Acuna, and W. Apt, HLA antigens in cardiomyopathic Chilean chagasics, Am J Hum Genet, vol.43, issue.5, pp.770-773, 1988.

E. Llop, F. Rothhammer, M. Acuna, W. Apt, and A. Arribada, HLA antigens in Chagas cardiomyopathy: new evidence based on a case?control study, Rev Med Chil, vol.119, issue.6, pp.633-636, 1991.

M. Fernandez-mestre, Z. Layrisse, S. Montagnani, H. Acquatella, F. Catalioti et al., Influence of the HLA class II polymorphism in chronic Chagas' disease, Parasite Immunol, vol.20, issue.4, pp.197-203, 1998.

Z. Layrisse, M. Fernandez, S. Montagnani, M. Matos, O. Balbas et al., HLA-C???03 is a risk factor for cardiomyopathy in chagas disease, Human Immunology, vol.61, issue.9, pp.61925-929, 2000.
DOI : 10.1016/S0198-8859(00)00161-0

N. Deghaide, R. Dantas, and E. Donadi, HLA class I and II profiles of patients presenting with Chagas' disease, Digestive Diseases and Sciences, vol.43, issue.2, pp.246-252, 1998.
DOI : 10.1023/A:1018829600200

I. Colorado, H. Acquatella, F. Catalioti, M. Fernandez, and Z. Layrisse, HLA class II DRB1, DQB1, DPB1 polymorphism and cardiomyopathy due to Trypanosoma cruzi chronic infection, Human Immunology, vol.61, issue.3, pp.61320-325, 2000.
DOI : 10.1016/S0198-8859(99)00177-9

J. Rodriguez-perez, D. Cruz-robles, G. Hernandez-pacheco, N. Perez-hernandez, L. Murguia et al., Tumor necrosis factor-alpha promoter polymorphism in Mexican patients with Chagas??? disease, Immunology Letters, vol.98, issue.1, pp.97-102, 2005.
DOI : 10.1016/j.imlet.2004.10.017

V. Campelo, R. Dantas, R. Simoes, C. Mendes-junior, S. Sousa et al., TNF Microsatellite Alleles in Brazilian Chagasic Patients, Digestive Diseases and Sciences, vol.38, issue.12, pp.3334-3339, 2007.
DOI : 10.1007/s10620-006-9699-7

S. Drigo, E. Cunha-neto, B. Ianni, C. Mady, K. Fae et al., Lack of association of tumor necrosis factor-?? polymorphisms with Chagas disease in Brazilian patients, Immunology Letters, vol.108, issue.1, pp.109-111, 2007.
DOI : 10.1016/j.imlet.2006.10.008

Y. Beraun, A. Nieto, M. Collado, A. Gonzalez, and J. Martin, Polymorphisms at tumor necrosis factor (TNF) loci are not associated with Chagas' disease, Tissue Antigens, vol.24, issue.1, pp.81-83, 1998.
DOI : 10.1111/j.1399-0039.1998.tb03028.x

S. Drigo, E. Cunha-neto, B. Ianni, M. Cardoso, P. Braga et al., TNF gene polymorphisms are associated with reduced survival in severe Chagas' disease cardiomyopathy patients, Microbes and Infection, vol.8, issue.3, pp.598-603, 2006.
DOI : 10.1016/j.micinf.2005.08.009

O. Florez, J. Martin, and C. Gonzalez, Interleukin 4, interleukin 4 receptor-?? and interleukin 10 gene polymorphisms in Chagas disease, Parasite Immunology, vol.104, issue.Suppl 1, pp.506-511, 2011.
DOI : 10.1111/j.1365-3024.2011.01314.x

D. Cruz-robles, J. Chavez-gonzalez, M. Cavazos-quero, O. Perez-mendez, P. Reyes et al., Association between IL-1B and IL-1RN gene polymorphisms and Chagas' disease development susceptibility, Immunol Invest, vol.38, pp.3-4231, 2009.

G. Costa, M. Da-costa-rocha, P. Moreira, C. Menezes, M. Silva et al., Functional IL???10 Gene Polymorphism Is Associated with Chagas Disease Cardiomyopathy, The Journal of Infectious Diseases, vol.199, issue.3, pp.199451-454, 2009.
DOI : 10.1086/596061

M. Moreno, E. Silva, L. Ramirez, L. Palacio, D. Rivera et al., Chagas' disease susceptibility/resistance: linkage disequilibrium analysis suggests epistasis between major histocompatibility complex and interleukin-10, Tissue Antigens, vol.159, issue.1, pp.18-24, 2004.
DOI : 10.1034/j.1399-0039.2001.057004353.x

G. Zafra, C. Morillo, J. Martin, A. Gonzalez, and C. Gonzalez, Polymorphism in the 3??? UTR of the IL12B gene is associated with Chagas??? disease cardiomyopathy, Microbes and Infection, vol.9, issue.9, pp.1049-1052, 2007.
DOI : 10.1016/j.micinf.2007.04.010

R. Ramasawmy, E. Cunha-neto, K. Fae, S. Borba, P. Teixeira et al., Heterozygosity for the S180L variant of MAL/TIRAP, a gene expressing an adaptor protein in the Toll-like receptor pathway, is associated with lower risk of developing chronic Chagas cardiomyopathy, J Infect Dis, issue.12, pp.1991838-1845, 2009.

R. Ramasawmy, E. Cunha-neto, K. Fae, F. Martello, N. Muller et al., The Monocyte Chemoattractant Protein???1 Gene Polymorphism Is Associated with Cardiomyopathy in Human Chagas Disease, Clinical Infectious Diseases, vol.43, issue.3, pp.43305-311, 2006.
DOI : 10.1086/505395

R. Ramasawmy, E. Cunha-neto, K. Fae, N. Muller, V. Cavalcanti et al., a Putative Anti???Inflammatory Gene, Is Associated with Chronic Chagas Cardiomyopathy, The Journal of Infectious Diseases, vol.193, issue.10, pp.1931394-1399, 2006.
DOI : 10.1086/503368

R. Ramasawmy, K. Fae, E. Cunha-neto, N. Muller, V. Cavalcanti et al., Polymorphisms in the gene for lymphotoxin-alpha predispose to chronic Chagas cardiomyopathy, J Infect Dis, issue.12, pp.1961836-1843, 2007.

C. Pissetti, R. De-oliveira, D. Correia, G. Nascentes, M. Llaguno et al., Association Between the Lymphotoxin-Alpha Gene Polymorphism and Chagasic Cardiopathy, Journal of Interferon & Cytokine Research, vol.33, issue.3, pp.130-135
DOI : 10.1089/jir.2012.0024

R. Ramasawmy, K. Fae, E. Cunha-neto, S. Borba, B. Ianni et al., Variants in the promoter region of IKBL/NFKBIL1 gene may mark susceptibility to the development of chronic Chagas??? cardiomyopathy among Trypanosoma cruzi-infected individuals, Molecular Immunology, vol.45, issue.1, pp.283-288, 2008.
DOI : 10.1016/j.molimm.2007.04.015

J. Calzada, A. Nieto, Y. Beraun, and J. Martin, Chemokine receptor CCR5 polymorphisms and Chagas' disease cardiomyopathy, Tissue Antigens, vol.94, issue.3, pp.154-158, 2001.
DOI : 10.1073/pnas.96.10.5698

M. Fernandez-mestre, S. Montagnani, and Z. Layrisse, Is the CCR5-59029-G/G genotype a protective factor for cardiomyopathy in Chagas disease?, Human Immunology, vol.65, issue.7, pp.725-728, 2004.
DOI : 10.1016/j.humimm.2004.05.002

O. Torres, J. Calzada, Y. Beraun, C. Morillo, C. Gonzalez et al., Association of the macrophage migration inhibitory factor ???173G/C polymorphism with Chagas disease, Human Immunology, vol.70, issue.7, pp.543-546, 2009.
DOI : 10.1016/j.humimm.2009.04.022

O. Torres, J. Calzada, Y. Beraun, C. Morillo, A. Gonzalez et al., Role of the IFNG +874T/A polymorphism in Chagas disease in a Colombian population, Infection, Genetics and Evolution, vol.10, issue.5, pp.682-685, 2010.
DOI : 10.1016/j.meegid.2010.03.009

E. Cunha-neto and K. J. , Autoimmunity in Chagas' heart disease, Sao Paulo Medical Journal, vol.113, issue.2, pp.757-766, 1995.
DOI : 10.1590/S1516-31801995000200005

P. Teixeira, A. Frade, L. Nogueira, J. Kalil, C. Chevillard et al., Pathogenesis of Chagas disease cardiomyopathy, World Journal of Clinical Infectious Diseases, vol.2, issue.3, pp.39-53
DOI : 10.5495/wjcid.v2.i3.39

R. Vasconcelos, S. Montenegro, E. Azevedo, Y. Gomes, and C. Morais, Genetic susceptibility to chronic Chagas disease: An overview of single nucleotide polymorphisms of cytokine genes, Cytokine, vol.59, issue.2, pp.203-208
DOI : 10.1016/j.cyto.2012.04.035

K. Fae, S. Drigo, E. Cunha-neto, B. Ianni, C. Mady et al., HLA and ??-myosin heavy chain do not influence susceptibility to Chagas' disease cardiomyopathy, Microbes and Infection, vol.2, issue.7, pp.745-751, 2000.
DOI : 10.1016/S1286-4579(00)00501-3

T. Weitzel, I. Zulantay, I. Danquah, L. Hamann, R. Schumann et al., Mannose-Binding Lectin and Toll-Like Receptor Polymorphisms and Chagas Disease in Chile, American Journal of Tropical Medicine and Hygiene, vol.86, issue.2, pp.229-232
DOI : 10.4269/ajtmh.2012.11-0539

M. Jorge, T. Macedo, R. Janones, D. Carizzi, R. Heredia et al., Types of arrhythmia among cases of American trypanosomiasis, compared with those in other cardiology patients, Annals of Tropical Medicine & Parasitology, vol.60, issue.2, pp.139-148, 2003.
DOI : 10.1016/0002-9149(72)90417-1

D. Van-veldhuisen, G. Linssen, T. Jaarsma, W. Van-gilst, A. Hoes et al., B-Type Natriuretic Peptide and Prognosis in Heart Failure Patients With Preserved and Reduced Ejection Fraction, Journal of the American College of Cardiology, vol.61, issue.14, pp.611498-1506
DOI : 10.1016/j.jacc.2012.12.044

J. Januzzi and . Jr, Natriuretic Peptides, Ejection Fraction, and Prognosis, Journal of the American College of Cardiology, vol.61, issue.14, pp.611507-1509
DOI : 10.1016/j.jacc.2013.01.039
URL : http://doi.org/10.1016/j.jacc.2013.01.039

A. Barretto, E. Arteaga, C. Mady, B. Ianni, G. Bellotti et al., Male sex. Prognostic factor in Chagas' disease, Arq Bras Cardiol, vol.60, issue.4, pp.225-227, 1993.

A. Basquiera, A. Sembaj, A. Aguerri, M. Omelianiuk, S. Guzman et al., Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction, Heart, vol.89, issue.10, pp.891186-1190, 2003.
DOI : 10.1136/heart.89.10.1186

O. Florez, J. Martin, and C. Gonzalez, Genetic variants in the chemokines and chemokine receptors in Chagas disease, Human Immunology, vol.73, issue.8, pp.852-858
DOI : 10.1016/j.humimm.2012.04.005

A. Marino, A. Da-silva, P. Santos, L. Pinto, R. Gazzinelli et al., Regulated on Activation, Normal T Cell Expressed and Secreted (RANTES) Antagonist (Met-RANTES) Controls the Early Phase of Trypanosoma cruzi-Elicited Myocarditis, Circulation, vol.110, issue.11, pp.1101443-1449, 2004.
DOI : 10.1161/01.CIR.0000141561.15939.EC

G. Medeiros, J. Silverio, A. Marino, E. Roffe, V. Vieira et al., Treatment of chronically Trypanosoma cruzi-infected mice with a CCR1/CCR5 antagonist (Met-RANTES) results in amelioration of cardiac tissue damage, Microbes and Infection, vol.11, issue.2, pp.264-273, 2009.
DOI : 10.1016/j.micinf.2008.11.012

A. Marino, A. Silva, P. Santos, L. Pinto, R. Gazinelli et al., CC-chemokine receptors: a potential therapeutic target for Trypanosoma cruzi-elicited myocarditis, Mem??rias do Instituto Oswaldo Cruz, vol.100, issue.1, pp.93-96, 2005.
DOI : 10.1590/S0074-02762005000900015